Literature DB >> 20376097

Duration and level of transgene expression after gene electrotransfer to skin in mice.

A Gothelf1, J Eriksen, P Hojman, J Gehl.   

Abstract

In development of novel vaccines, attention is drawn to DNA vaccinations. They are heat stable and can be easily produced. Gene electrotransfer is a simple and nonviral means of transferring DNA to cells and tissues and is attracting increasing interest. One very interesting perspective with gene electrotransfer is that choice of tissue can determine the duration of transgene expression. With gene electrotransfer to muscle, long-term expression, that is beyond 1 year, can be obtained, whereas gene electrotransfer to skin gives short-term expression, which is desirable in, for example, DNA vaccinations. Level and duration of transgene expression after gene electrotransfer to skin is essential and here we present data from two independent quantitative studies. Using in vivo bioimaging of a far-red fluorescent molecule, Katushka, allowing for continuous monitoring of local gene expression, compared with measurements of a systemic transgene, that is, serum erythropoietin (EPO) after gene electrotransfer with EPO to skin, we found a significant increase in transgene expression (P< 0.01) with a peak 9 days (Katushka) and 14 days (EPO) after transfection. Duration of expression could be 3-4 weeks, which is a suitable time frame for vaccinations and is applicable, for example, in gene therapy for wound healing or treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20376097     DOI: 10.1038/gt.2010.35

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  10 in total

1.  Comparison of plasmid vaccine immunization schedules using intradermal in vivo electroporation.

Authors:  David Hallengärd; B Kristian Haller; Anna-Karin Maltais; Eva Gelius; Kopek Nihlmark; Britta Wahren; Andreas Bråve
Journal:  Clin Vaccine Immunol       Date:  2011-07-13

Review 2.  What you always needed to know about electroporation based DNA vaccines.

Authors:  Anita Gothelf; Julie Gehl
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

3.  Electro-gene transfer to skin using a noninvasive multielectrode array.

Authors:  Siqi Guo; Amy Donate; Gaurav Basu; Cathryn Lundberg; Loree Heller; Richard Heller
Journal:  J Control Release       Date:  2011-01-22       Impact factor: 9.776

4.  Electrotransfection and lipofection show comparable efficiency for in vitro gene delivery of primary human myoblasts.

Authors:  Tomaz Mars; Marusa Strazisar; Katarina Mis; Nejc Kotnik; Katarina Pegan; Jasna Lojk; Zoran Grubic; Mojca Pavlin
Journal:  J Membr Biol       Date:  2014-12-23       Impact factor: 1.843

5.  Numerical optimization of gene electrotransfer into muscle tissue.

Authors:  Anze Zupanic; Selma Corovic; Damijan Miklavcic; Mojca Pavlin
Journal:  Biomed Eng Online       Date:  2010-11-04       Impact factor: 2.819

6.  Minicircle DNA is superior to plasmid DNA in eliciting antigen-specific CD8+ T-cell responses.

Authors:  Wynette M Dietz; Nicole E B Skinner; Sara E Hamilton; Michelle D Jund; Suzanne M Heitfeld; Adam J Litterman; Patrick Hwu; Zhi-Ying Chen; Andres M Salazar; John R Ohlfest; Bruce R Blazar; Christopher A Pennell; Mark J Osborn
Journal:  Mol Ther       Date:  2013-05-21       Impact factor: 11.454

7.  Evaluation of immunogen delivery by DNA immunization using non-invasive bioluminescence imaging.

Authors:  Stefan P Petkov; Frank Heuts; Olga A Krotova; Athina Kilpelainen; Gunnel Engström; Elizaveta S Starodubova; Maria G Isaguliants
Journal:  Hum Vaccin Immunother       Date:  2013-07-03       Impact factor: 3.452

8.  A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines.

Authors:  David Hallengärd; Andreas Bråve; Maria Isaguliants; Pontus Blomberg; Jenny Enger; Richard Stout; Alan King; Britta Wahren
Journal:  Genet Vaccines Ther       Date:  2012-08-08

9.  Electroporation-delivered transdermal neostigmine in rats: equivalent action to intravenous administration.

Authors:  Szilvia Berkó; Kálmán F Szűcs; Boglárka Balázs; Erzsébet Csányi; Gábor Varju; Anita Sztojkov-Ivanov; Mária Budai-Szűcs; Judit Bóta; Róbert Gáspár
Journal:  Drug Des Devel Ther       Date:  2016-05-19       Impact factor: 4.162

10.  A Comparison of Red Fluorescent Proteins to Model DNA Vaccine Expression by Whole Animal In Vivo Imaging.

Authors:  Ekaterina Kinnear; Lisa J Caproni; John S Tregoning
Journal:  PLoS One       Date:  2015-06-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.